| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 50% | 13/26 |
| Female | 50% | 13/26 |
| Indifferent | 0% | 0/26 |
| Unknown | 0% | 0/26 |
| General | ||
| 23.1% | 6/26 | |
| 23.1% | 6/26 | |
| 7.7% | 2/26 | |
| 19.2% | 5/26 | |
| 30.8% | 8/26 | |
| 15.4% | 4/26 | |
| 92% | 23/25 | |
| 100% | 24/24 | |
| 96.2% | 25/26 | |
| 76.9% | 20/26 | |
| Neurology | ||
| 92.3% | 24/26 | |
| 65.4% | 17/26 | |
| 61.5% | 16/26 | |
| Facial abnormalities | ||
| 19.2% | 5/26 | |
| 96.2% | 25/26 | |
| 96.2% | 25/26 | |
| 92.3% | 24/26 | |
| Visual and hearing impairments | ||
| 11.5% | 3/26 | |
| 50% | 13/26 | |
| Heart | ||
| 7.7% | 2/26 | |
| Pulmonary | ||
| Abnormality of the lungs | 0% | 0/1 |
| Gastrointestinal | ||
| 34.6% | 9/26 | |
| Urogenital | ||
| 11.5% | 3/26 | |
| Skeleton | ||
| 61.5% | 16/26 | |
| Skin / Hair / Nails | ||
| 50% | 13/26 | |
| Endocrine / Immunological / Metabolic | ||
| Endocrine | 0% | 0/26 |
| 3.8% | 1/26 | |
| 26.9% | 7/26 | |
| Neoplasia | ||
| Neoplasia | 0% | 0/26 |
| Inheritance | ||
| 100% | 25/25 | |
WDR26